UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI ...

Big questions remain about whether the UK can remain aligned with the European Medicines Agency, without which the pharma industry has warned that the UK could be relegated from its current ...

We asked Tom Delahoyde, managing director at Chiesi UK & Republic of Ireland, his thoughts on the industry’s role in achieving a sustainable future. Why is the pharmaceutical industry so ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the ...

The UK government plans to raise the Statutory Scheme payment rate for newer branded medicines from 15.5% to 32.2% of subject ...

The UK has announced plans to abolish NHS England and integrate its functions into the central government, marking a ...

Novo Nordisk A/S (NYSE:NVO) returned to full membership of the Association of the British Pharmaceutical Industry (ABPI) ...

Pharma and Biopharma is a trillion-dollar industry providing ample career opportunities for laboratory scientists and entrepreneurs. Join Principal Consultant Michael W. Dong of MWD Consulting as he ...